Astrana Health Q2 revenue rises, but misses estimates

Astrana Health

06/08/2026 21:39

Overview
US physician-centric healthcare firm's Q2 revenue rose 49% yr/yr but missed analyst expectations
Q2 adjusted EPS beat analyst expectations, rising 45% yr/yr
Company raised full-year adjusted EBITDA guidance after strong Q2 performance

Outlook
Astrana Health sees Q3 revenue between $1.0 bln and $1.03 bln
Company expects Q3 adjusted EBITDA of $72.5 mln to $77.5 mln
Astrana Health raises 2026 adjusted EBITDA guidance to $255 mln-$280 mln, reaffirms revenue and free cash flow outlook

Result Drivers
PLATFORM DEMAND - Co said accelerating demand from providers and payers for its physician-centric, AI-native healthcare platform drove growth
VALUE-BASED CARE EXPANSION - Co cited expansion of Medicare Advantage footprint and new agreements in Hawaii and Texas as growth drivers

Company press release: ID:nPn4JPyB3a

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Adjusted EPS
Beat
$0.80
$0.34 (10 Analysts)
Q2 EPS
 
$0.40
 
Q2 Adjusted EBITDA
Beat
$68.90 mln
$67.69 mln (9 Analysts)

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Astrana Health, Inc. is $50.00, about 39.5% above its August 5 closing price of $35.83
The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 23 three months ago

Reuters Recommended Reads
Aug 5 - Clover Health Q2 revenue rises 56%, beating estimates on memership growth
Aug 5 - Agilon Health Q2 revenue beats estimates, raises outlook
Aug 6 - Privia Health Q2 revenue beats estimates, outlook raised

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)